-
Mashup Score: 33
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0AI and Drug Development: The future? - 3 day(s) ago
In this special episode of Healthcare Unfiltered, I delve into the realm of AI and its transformative impact on drug development with Adam Petrich, MD, Chief…
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results r…
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4
Show Healthcare Unfiltered, Ep AI and Drug Development With Adam Petrich – Apr 23, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results r…
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results r…
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results r…
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results r…
Source: www.nejm.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9The ABIM-MOC Saga Continues - 11 day(s) ago
Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as NOT CERTI…
Source: www.youtube.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 33
Show Healthcare Unfiltered, Ep The ABIM-MOC Saga Continues – Apr 16, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet
My latest #HemOnc Pulse is out W @ManniMD1 & @ASkarbnik discussing the "concept of MRD" in Heme malignancies. Impact of MRD likely varies based on the Dx & goals of Tx, but it is critical to address. Listen to the entire discussion here @Blood_Cancers https://t.co/S93jVt0nqp